This report contains market size and forecasts of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Global, including the following market information:
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market was valued at 5330.8 million in 2020 and is projected to reach US$ 6884.5 million by 2027, at a CAGR of 6.6% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, By Type, 2020 (%)
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others

China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, By Application, 2020 (%)
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others

Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer